A phase II study of carbon-ion radiotherapy combined with anti-tumor agents for mucosal malignant melanoma of the head and neck
Not Applicable
- Conditions
- mucosal malignant melanoma of the head and neck
- Registration Number
- JPRN-UMIN000023182
- Lead Sponsor
- Kanagawa Cancer Center, Kanagawa Prefectural Hospital Organization
- Brief Summary
This study confirmed safety and efficacy comparable to those reported from prior facilities.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patient with past history of radiotherapy for the targeted lesion 2)Patient is within 2 weeks after the final chemoterapy 3)Patient with active double cancer 4)Patients with active and intractable infection in the targeted lesion 5) Patient with metal devices in the lesion 6) Other medical or psychological condition which is unsuitable for carbon-ion therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year survival rate
- Secondary Outcome Measures
Name Time Method 1) Local control rate 2) Disease-specific survival 3) Early and late adverse event rate 4) Local response rate